BRPI0809936A2 - Composto sulfonado de açúcar e uso do mesmo como medicamento - Google Patents
Composto sulfonado de açúcar e uso do mesmo como medicamentoInfo
- Publication number
- BRPI0809936A2 BRPI0809936A2 BRPI0809936-7A2A BRPI0809936A BRPI0809936A2 BR PI0809936 A2 BRPI0809936 A2 BR PI0809936A2 BR PI0809936 A BRPI0809936 A BR PI0809936A BR PI0809936 A2 BRPI0809936 A2 BR PI0809936A2
- Authority
- BR
- Brazil
- Prior art keywords
- medicinal product
- sugar compound
- sulfonated
- sulfonated sugar
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007190120 | 2007-07-20 | ||
PCT/JP2008/063056 WO2009014101A1 (ja) | 2007-07-20 | 2008-07-18 | 新規なスルホン酸化糖誘導体およびその医薬としての使用 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0809936A2 true BRPI0809936A2 (pt) | 2014-10-07 |
Family
ID=40281352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0809936-7A2A BRPI0809936A2 (pt) | 2007-07-20 | 2008-07-18 | Composto sulfonado de açúcar e uso do mesmo como medicamento |
Country Status (10)
Country | Link |
---|---|
US (2) | US7973145B2 (pt) |
EP (1) | EP2130834A4 (pt) |
JP (1) | JP4435861B2 (pt) |
KR (1) | KR101136601B1 (pt) |
CN (1) | CN101641365B (pt) |
AU (1) | AU2008278337B2 (pt) |
BR (1) | BRPI0809936A2 (pt) |
CA (1) | CA2679915C (pt) |
EA (1) | EA016931B1 (pt) |
WO (1) | WO2009014101A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9950194B2 (en) | 2014-09-09 | 2018-04-24 | Mevion Medical Systems, Inc. | Patient positioning system |
CN106380400B (zh) * | 2016-02-04 | 2018-12-11 | 浙江省中医药研究院 | 一种萜品烯醇类化合物及其制备方法和应用 |
JP6621158B1 (ja) * | 2019-03-05 | 2019-12-18 | 株式会社エム・ティー・スリー | 放射線増感剤 |
JP6903273B1 (ja) * | 2020-09-25 | 2021-07-14 | 株式会社エム・ティー・スリー | 化合物又はその塩、及び放射性増感剤 |
JP2024056658A (ja) | 2022-10-11 | 2024-04-23 | 株式会社エム・ティー・スリー | 医薬組成物 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE113210T1 (de) | 1989-08-15 | 1994-11-15 | Us Health | Antivirale zusammensetzungen enthaltend sulfoquinovosylglycerolderivate und analoge davon. |
JP4454051B2 (ja) * | 1997-01-24 | 2010-04-21 | 東洋水産株式会社 | 新規な糖脂質、その製造方法及びその用途 |
JP3851461B2 (ja) * | 1998-09-04 | 2006-11-29 | 東洋水産株式会社 | ピラノシドおよびその製造方法 |
JP4224429B2 (ja) * | 1998-09-04 | 2009-02-12 | 東洋水産株式会社 | スルホキノボシルアシルグリセロール |
CN1151795C (zh) * | 1999-02-26 | 2004-06-02 | 东洋水产株式会社 | 含(磺基吡喃糖基)酰基甘油衍生物的药品 |
US6518410B2 (en) * | 1999-02-26 | 2003-02-11 | Toyo Suisan Kaisha, Ltd. | Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments |
CN1155391C (zh) * | 1999-03-11 | 2004-06-30 | 东洋水产株式会社 | 新颖的免疫抑制剂 |
JP4913289B2 (ja) * | 2001-05-23 | 2012-04-11 | 備前化成株式会社 | カスパーゼ阻害剤 |
JP4281377B2 (ja) | 2003-02-26 | 2009-06-17 | 東レ株式会社 | 液晶性ポリエステルおよびその組成物 |
ATE479695T1 (de) * | 2004-06-24 | 2010-09-15 | Toyo Suisan Kaisha | Sulfopyranosylacylglycerol-derivate zur anwendung in kombination mit bestrahlung in einer tumor- radiotherapie |
-
2008
- 2008-07-18 EA EA200970779A patent/EA016931B1/ru not_active IP Right Cessation
- 2008-07-18 CN CN200880009161XA patent/CN101641365B/zh not_active Expired - Fee Related
- 2008-07-18 BR BRPI0809936-7A2A patent/BRPI0809936A2/pt not_active IP Right Cessation
- 2008-07-18 WO PCT/JP2008/063056 patent/WO2009014101A1/ja active Application Filing
- 2008-07-18 CA CA2679915A patent/CA2679915C/en not_active Expired - Fee Related
- 2008-07-18 KR KR1020097019551A patent/KR101136601B1/ko not_active IP Right Cessation
- 2008-07-18 JP JP2009524477A patent/JP4435861B2/ja not_active Expired - Fee Related
- 2008-07-18 EP EP08778289A patent/EP2130834A4/en not_active Withdrawn
- 2008-07-18 AU AU2008278337A patent/AU2008278337B2/en not_active Ceased
-
2009
- 2009-01-29 US US12/322,151 patent/US7973145B2/en not_active Expired - Fee Related
-
2010
- 2010-07-30 US US12/804,808 patent/US20100298246A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2008278337B2 (en) | 2011-09-29 |
CN101641365A (zh) | 2010-02-03 |
US20100298246A1 (en) | 2010-11-25 |
JP4435861B2 (ja) | 2010-03-24 |
CA2679915A1 (en) | 2009-01-29 |
EP2130834A1 (en) | 2009-12-09 |
US7973145B2 (en) | 2011-07-05 |
AU2008278337A1 (en) | 2009-01-29 |
WO2009014101A1 (ja) | 2009-01-29 |
KR101136601B1 (ko) | 2012-04-23 |
KR20090122451A (ko) | 2009-11-30 |
EP2130834A4 (en) | 2012-09-05 |
JPWO2009014101A1 (ja) | 2010-10-07 |
EA200970779A1 (ru) | 2010-04-30 |
CN101641365B (zh) | 2013-01-16 |
CA2679915C (en) | 2012-10-30 |
EA016931B1 (ru) | 2012-08-30 |
US20090209475A1 (en) | 2009-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2131813T3 (da) | Topiske, farmaceutiske formuleringer | |
BRPI0819073A2 (pt) | fralda descartável | |
BRPI0821276A2 (pt) | Produto, e, uso do produto | |
BRPI1010621A2 (pt) | derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso | |
BRPI0821668A2 (pt) | Uso | |
BRPI0807453A2 (pt) | Preparação sólida | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
DK2151438T3 (da) | Lægemiddel indeholdende PPAR-Deltaagonist | |
BRPI0817310A2 (pt) | Ensaio de monitoramento de fármaco | |
BRPI0719394A2 (pt) | Preparação medicinal sólida | |
BRPI0812753A2 (pt) | Combinações de substância ativas acaricidas | |
ATE493119T1 (de) | Pharmazeutische zusammensetzung | |
DK2125048T3 (da) | Præparat | |
BRPI0819071A2 (pt) | fralda descartável | |
BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
BRPI0821915A2 (pt) | Piridil-n-(1,3,4)-tiadiazol-2-il-benzeno sulfonamidas cíclicas, processos para sua preparação e seu uso como produtos farmacêuticos | |
BRPI0919807A2 (pt) | compostos nitrogenosos heterocíclicos , sua preparação e seu uso como medicamentos antibacterianos | |
DK2182988T3 (da) | Radiofarmaceutisk præparat | |
BRPI1015943A2 (pt) | derivados de 1,2,3,4-tetra - hidro - pirimido [1,2-a] pirimidin-6-ona, o respectivo preparo e a respectiva utilização farmacêutica. | |
BRPI0920502A2 (pt) | compostos cicloundecadepsipeptídeos e seu uso como medicamento | |
BRPI0906727A2 (pt) | Azaindol-3-carboxamidas cíclicas, sua preparação e seu uso como produtos farmacêuticos | |
BRPI0809936A2 (pt) | Composto sulfonado de açúcar e uso do mesmo como medicamento | |
BRPI0720309A2 (pt) | Análogos de epotilona modificados nas posições c12 - c13 como fármacos anticâncer | |
BRPI0813937A2 (pt) | Derivado de 17beta-ciano-19-nor-andros-4-eno, seu uso e medicamentos contendo o derivado | |
FI20080348A0 (fi) | Uudenlainen farmaseuttinen formulaatio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |